Entrez PubMed
Overview
Help |
FAQ
Tutorial
New/Noteworthy
PubMed Services
Journal Browser
MeSH Browser
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
LinkOut
Cubby
Related Resources
Order Documents
NLM Gateway
Consumer Health
Clinical Alerts
ClinicalTrials.gov
PubMed Central
Privacy Policy
|
|
-
NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, Abeta(1-40)ox and Abeta(1-42)ox.
Riek R, Guntert P, Dobeli H, Wipf B, Wuthrich K.
Institut fur Molekularbiolgie und Biophysik, Eidgenossische Technische Hochschule-Honggerberg, Zurich, Switzerland; Hoffmann-La Roche Ltd, Basel, Switzerland.
NMR studies of amyloid beta-peptides (Abeta) in aqueous solution provide a novel way in which to characterize the apparent Alzheimer's disease-related conformational polymorphism of Abeta. In the aqueous medium, neither of the polypeptides Abeta(1-40)ox or Abeta(1-42)ox (both of which contain a methionine sulfoxide at position 35) is folded into a globular structure, but they both deviate from random coil behavior by local conformational preferences of several short segments along the amino-acid sequence. Differences between the solution structures of Abeta(1-40)ox and Abeta(1-42)ox are indicated only by decreased flexibility of the region from about residue 32 to the C-terminus in Abeta(1-42)ox when compared to Abeta(1-40)ox. The lack of the observation of more extensive conformational differences between the two molecules is intriguing, considering that Abeta(1-42)ox in aqueous solution has much higher plaque-competence than Abeta(1-40)ox.
PMID: 11722581 [PubMed - in process]
|